Yield10 Bioscience, Inc.

YTEN · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$14,455-$13,566-$11,031-$10,206
Dep. & Amort.$290$263$220$182
Deferred Tax$0$165$35$56
Stock-Based Comp.$1,592$1,903$1,675$739
Change in WC$2,089-$695-$622-$798
Other Non-Cash$416$526$470$1,368
Operating Cash Flow-$10,068-$11,404-$9,253-$8,659
Investing Activities
PP&E Inv.-$46-$154-$189-$76
Net Acquisitions$0-$8,676$4,389$10
Inv. Purchases$0-$2,445-$10,639-$9,279
Inv. Sales/Matur.$1,991$11,121$6,250$8,700
Other Inv. Act.$0$8,676-$4,389-$569
Investing Cash Flow$1,945$8,522-$4,578-$645
Financing Activities
Debt Repay.$967$0$0$333
Stock Issued$103$0$11,993$5,305
Stock Repurch.$0-$37$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$5,801-$37$3,753$1,641
Financing Cash Flow$6,871-$37$15,746$7,279
Forex Effect-$36-$54-$9-$37
Net Chg. in Cash-$1,288-$2,973$1,906-$2,062
Supplemental Information
Beg. Cash$2,620$5,593$3,687$5,749
End Cash$1,332$2,620$5,593$3,687
Free Cash Flow-$10,114-$11,558-$9,442-$8,735
Yield10 Bioscience, Inc. (YTEN) Financial Statements & Key Stats | AlphaPilot